OIF

The Open Insulin Foundation (OIF) is a non-profit biotechnology organization dedicated to developing open-source protocols for the production of insulin. By leveraging community-based research and citizen science, the foundation aims to create a decentralized, low-cost manufacturing model that bypasses traditional pharmaceutical patent barriers. Their work focuses on engineering microorganisms to produce insulin analogues, such as glargine and lispro, and establishing small-scale, GMP-compliant production facilities. OIF's mission is to democratize access to life-saving medicine by providing the tools and knowledge for local communities to produce their own affordable insulin.